A clinical study of sacituzumab tirumotecan (sac-TMT) in people with bladder cancer (MK-2870-027)

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514983-23-01

Acronym

MK-2870-027

Enrollment

Registered

2024-12-13

Start date

2024-12-16

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermediate-risk Non-muscle Invasive Bladder Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026